Baxter International(BAX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low22.35
Day High22.72
Open:22.64
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Citi Sticks to Its Sell Rating for Baxter International (BAX)
StockStory
3 Healthcare Stocks We Think Twice About
BAX
StockStory
3 Value Stocks We Keep Off Our Radar
BFAM
Zacks Investment Research
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?
Tipranks
Baxter International (BAX) Gets a Hold from Bank of America Securities
StockStory
3 Unpopular Stocks We’re Skeptical Of
BAX
StockStory
Why Baxter (BAX) Shares Are Sliding Today
BAX
StockStory
1 Stock Under $50 Worth Investigating and 2 Facing Challenges
RNG
StockStory
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
BAX
Tipranks
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Astrana Health (ASTH) and Baxter International (BAX)
StockStory
1 Unprofitable Stock to Keep an Eye On and 2 We Ignore
TTWO
Tipranks
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Capricor Therapeutics (CAPR)
MarketBeat
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting
MarketBeat.com
Tipranks
Baxter Updates Executive Severance Plan and Governance Framework
StockStory
5 Revealing Analyst Questions From Baxter’s Q1 Earnings Call
BAX
Tipranks
Baxter International (BAX) Receives a Hold from Stifel Nicolaus
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Alkermes (ALKS), Baxter International (BAX)
StockStory
Neogen and Baxter Shares Are Falling, What You Need To Know
NEOG
Tipranks
Goldman Sachs Remains a Hold on Baxter International (BAX)

Profile

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.